新型大鼠被动皮肤过敏反应口服活性抑制剂：N-[2-(4-吡啶基)-4-嘧啶基]脲和二烷基[[[2-(4-吡啶基)-4-嘧啶基]氨基]亚甲基]丙二酸酯。
Novel orally active inhibitors of passive cutaneous anaphylaxis in rats: N-[2-(4-pyridinyl)-4-pyrimidinyl]ureas and dialkyl [[[2-(4-pyridinyl)-4-pyrimidinyl]amino]methylene]malonates.
作者信息
Lesher G Y, Singh B, Mielens Z E
出版信息
J Med Chem. 1982 Jul;25(7):837-42. doi: 10.1021/jm00349a014.
PMID:6180166
Abstract
4-Chloro-2-(4-pyridinyl)pyrimidines were treated with alkylamines to afford the corresponding N-substituted amino derivatives. 4-Amino-2-(4-pyridinyl)pyrimidines and their N-substituted analogues were converted to amides, carbamates, aminomethylenemalonates, and ureas. Many of these compounds were found to have potential antiallergic activity as indicated by the rat passive cutaneous anaphylaxis screen. The most compounds were found in the last two series.
摘要
将4-氯-2-(4-吡啶基)嘧啶与烷基胺反应，得到相应的N-取代氨基衍生物。4-氨基-2-(4-吡啶基)嘧啶及其N-取代类似物被转化为酰胺、氨基甲酸酯、氨基亚甲基丙二酸酯和脲。大鼠被动皮肤过敏反应筛选表明，这些化合物中的许多具有潜在的抗过敏活性。在最后两个系列中发现的化合物最多。
相似文献
1
Novel orally active inhibitors of passive cutaneous anaphylaxis in rats: N-[2-(4-pyridinyl)-4-pyrimidinyl]ureas and dialkyl [[[2-(4-pyridinyl)-4-pyrimidinyl]amino]methylene]malonates.新型大鼠被动皮肤过敏反应口服活性抑制剂：N-[2-(4-吡啶基)-4-嘧啶基]脲和二烷基[[[2-(4-吡啶基)-4-嘧啶基]氨基]亚甲基]丙二酸酯。
J Med Chem. 1982 Jul;25(7):837-42. doi: 10.1021/jm00349a014.
2
Synthesis of new 2-(2-phenylethenyl)-4-oxo-4H-pyrido[1,2-a]pyrimidine-7-carboxylic acids.新型2-(2-苯乙烯基)-4-氧代-4H-吡啶并[1,2-a]嘧啶-7-羧酸的合成
Farmaco Sci. 1984 Oct;39(10):837-45.
3
Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines.1,3-恶唑并[4,5-h]喹啉的合成及其抗过敏活性
J Med Chem. 1985 Sep;28(9):1255-9. doi: 10.1021/jm00147a023.
4
Synthesis of 2-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5-yl) benzo heterocycles. A novel series of orally active antiallergic agents.
J Med Chem. 1984 Feb;27(2):121-5. doi: 10.1021/jm00368a004.
5
Preparation of triazolo[1,5-c]pyrimidines as potential antiasthma agents.作为潜在抗哮喘药物的三唑并[1,5 - c]嘧啶的制备。
J Med Chem. 1990 Apr;33(4):1230-41. doi: 10.1021/jm00166a023.
6
Preparation of substituted N-phenyl-4-aryl-2-pyrimidinamines as mediator release inhibitors.作为介质释放抑制剂的取代N-苯基-4-芳基-2-嘧啶胺的制备
J Med Chem. 1993 Sep 17;36(19):2716-25. doi: 10.1021/jm00071a002.
7
Synthesis of 3,4-dihydro-4-oxothieno[2,3-d]pyrimidine-2-carboxylates, a new series of orally active antiallergy agents.新型口服活性抗过敏药物3,4-二氢-4-氧代噻吩并[2,3-d]嘧啶-2-羧酸酯的合成
J Med Chem. 1979 May;22(5):505-10. doi: 10.1021/jm00191a009.
8
Novel antiallergic agents. Part I: Synthesis and pharmacology of pyrimidine amide derivatives.
Bioorg Med Chem. 1998 Jul;6(7):1057-67. doi: 10.1016/s0968-0896(98)00064-9.
9
Studies on antiallergy agents. III. Synthesis of 2-anilino-1,6-dihydro-6-oxo-5-pyrimidinecarboxylic acids and related compounds.
Chem Pharm Bull (Tokyo). 1989 Jul;37(7):1780-7. doi: 10.1248/cpb.37.1780.
10
Quantitative structure-activity relationships in a series of antiallergic agents.一系列抗过敏药物中的定量构效关系。
Arzneimittelforschung. 1982;32(4):325-30.
Zotero 插件